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OBJECTIVE: 
Current materials for heart valve replacement and repair are limited by the inability to grow or 
remodel. Tissue engineered valves offer the potential to overcome these disadvantages by 
creating living structures, but is limited by the availability of biocompatible scaffold materials 
with desirable biomechanical properties. We assessed the in vivo performance of a novel 
scaffold poly(carbonate urethane) urea (PCUU), fabricated by electrospinning and implanted in 
the pulmonary outflow tract of sheep. 
METHODS: 
PCUU was electrospun into elastomeric sheets of thickness ranging from 120-180 μm. Using 
cardiopulmonary bypass we replaced the native anterior pulmonary leaflet with an acellular 
PCUU leaflet. Valve function was evaluated by epicardial echocardiography at implant and 
explant at weeks 1 (n=3), 3 (n=3), 6 (n=3) and 16 (n=3). Histological, immunohistochemical, 
molecular imaging analyses and multi-photon imaging were performed on the explanted leaflets. 
Cells were isolated from the explanted leaflets and characterized in-vitro. 
RESULTS: 
Echocardiography demonstrated mobile functioning leaflets, with zero to mild pulmonary 
regurgitation. Leaflet tissue did not shrink/contract in either radial or circumferential dimensions. 
Histology showed persistence of scaffold material up to 16 weeks with cellular infiltration 
throughout the leaflet. Picrosirius red revealed mature collagen deposition along the arterial 
surface of the construct at 6 and 16 weeks. These findings were corroborated by multi-photon 
analysis showing highly aligned collagen fibers across the leaflets. Movat pentachrome showed 
glycosaminoglycan and elastin formation at 16 weeks. Both surfaces of the engineered leaflets 
were consistently covered with CD31 positive cells. The majority of cells expressed α-SMA and 
MMP2. Sub-surface cells have shown co-localization of CD31 and α-SMA. Two phenotypically 
and functionally distinct cell types, similar to those of native valves, were identified in-vitro. 
CONCLUSIONS: 
These results suggest that: 1) PCUU can be a suitable polymer for valve bioengineering; 2) cell 
pre-seeding may not be required for tissue formation or remodeling for a functional engineered 
valve; 3) host cells seem to populate the leaflet and participate in active tissue remodeling 4) An 
endothelial to mesenchymal transformation process may play a 
 
